T1	Participants 510 518	children
T2	Participants 609 678	Twenty-two U.S. medical centers (including Puerto Rico) participated.
T3	Participants 688 790	Children diagnosed with CPP (n = 84), who were either treatment naive or previously treated with GnRHa
